CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 200 of 813 entries

View as:

Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED

Phase: N/A Priority: Normal

NCT ID: NCT03188861 Org: User:

Start: 06/01/17 End: 04/30/19 Due: 04/30/20

Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2

Phase: N/A Priority: Normal

NCT ID: NCT02340299 Org: User:

Start: 01/01/15 End: 12/31/17 Due: 12/31/18

Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making

Phase: N/A Priority: Normal

NCT ID: NCT03220386 Org: User:

Start: 05/01/17 End: 08/01/18 Due: 08/01/19

Robotic Assisted Early Mobilization in Ventilated ICU Patients

Phase: N/A Priority: Normal

NCT ID: NCT04423796 Org: User:

Start: 11/13/20 End: 09/12/22 Due: 09/12/23

Safety and Efficacy of Propionate for Reduction of LDL Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT03590496 Org: User:

Start: 07/25/18 End: 06/30/20 Due: 06/30/21

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

Phase: N/A Priority: Normal

NCT ID: NCT01045772 Org: User:

Start: 01/31/09 End: 09/30/10 Due: 09/30/11

Baclofen for the Treatment of Alcohol Dependence

Phase: N/A Priority: Normal

NCT ID: NCT01266655 Org: User:

Start: 02/28/11 End: 05/31/14 Due: 05/31/15

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02753036 Org: User:

Start: 01/01/16 End: 06/30/23 Due: 06/30/24

Acceptance of Complementary Medicine in Germany

Phase: N/A Priority: Normal

NCT ID: NCT05530720 Org: User:

Start: 09/19/22 End: 10/17/22 Due: 10/17/23

Cupping in Osteoarthritis of the Knee

Phase: N/A Priority: Normal

NCT ID: NCT01057043 Org: User:

Start: 01/31/10 End: 01/31/11 Due: 01/31/12

Prevalence of Wound Healing Disturbances in Geriatric Inpatients (WONDER Study)

Phase: N/A Priority: Normal

NCT ID: NCT03314350 Org: User:

Start: 11/01/17 End: 01/31/21 Due: 01/31/22

DIGIPREDICT-Physio-DE

Phase: N/A Priority: Normal

NCT ID: NCT05886569 Org: User:

Start: 05/25/23 End: 11/24/23 Due: 11/24/24

Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients

Phase: N/A Priority: Normal

NCT ID: NCT01992237 Org: User:

Start: 10/31/13 End: 06/30/18 Due: 06/30/19

Zevalin® First Line in Follicular Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT00772655 Org: User:

Start: 10/31/07 End: 06/30/15 Due: 06/30/16

OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT06136390 Org: User:

Start: 09/30/23 End: 12/30/24 Due: 12/30/25

Patient Survey as a Tool to Quality Assurance and Quality Improvement

Phase: N/A Priority: Normal

NCT ID: NCT02413775 Org: User:

Start: 04/30/15 End: 09/30/21 Due: 09/30/22

D2E7-Early AS

Phase: N/A Priority: Normal

NCT ID: NCT00235105 Org: User:

Start: 03/31/05 End: 06/30/07 Due: 06/30/08

Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders

Phase: N/A Priority: Normal

NCT ID: NCT03671005 Org: User:

Start: 05/01/18 End: 02/28/21 Due: 02/28/22

Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis

Phase: N/A Priority: Normal

NCT ID: NCT05231239 Org: User:

Start: 01/01/21 End: 01/31/23 Due: 01/31/24

Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients

Phase: N/A Priority: Normal

NCT ID: NCT05192655 Org: User:

Start: 12/01/21 End: 12/01/26 Due: 12/01/27

Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach

Phase: N/A Priority: Normal

NCT ID: NCT05334888 Org: User:

Start: 08/29/22 End: 12/31/27 Due: 12/31/28

Bilastine Updosing in Chronic Spontaneous Urticaria

Phase: N/A Priority: Normal

NCT ID: NCT02213367 Org: User:

Start: 07/31/14 End: 03/31/16 Due: 03/31/17

Intensive Care Unit Risk Score

Phase: N/A Priority: Normal

NCT ID: NCT04661735 Org: User:

Start: 01/01/06 End: 12/31/25 Due: 12/31/26

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Phase: N/A Priority: Normal

NCT ID: NCT05211011 Org: User:

Start: 01/23/18 End: 04/30/23 Due: 04/30/24

Cold Urticaria Treatment With Xolair

Phase: N/A Priority: Normal

NCT ID: NCT01580592 Org: User:

Start: 04/30/12 End: 02/28/15 Due: 02/28/16

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED	NCT03188861	Charite University, Berlin, Germany	user2@example.com	None	2017-06-01	2019-04-30	2020-04-30	-	-	2025-07-14
Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2	NCT02340299	Charite University, Berlin, Germany	user2@example.com	None	2015-01-01	2017-12-31	2018-12-31	-	-	2025-07-14
Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making	NCT03220386	Charite University, Berlin, Germany	user2@example.com	None	2017-05-01	2018-08-01	2019-08-01	-	-	2025-07-14
Robotic Assisted Early Mobilization in Ventilated ICU Patients	NCT04423796	Charite University, Berlin, Germany	user2@example.com	None	2020-11-13	2022-09-12	2023-09-12	-	-	2025-07-14
Safety and Efficacy of Propionate for Reduction of LDL Cholesterol	NCT03590496	Charite University, Berlin, Germany	user2@example.com	None	2018-07-25	2020-06-30	2021-06-30	-	-	2025-07-14
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)	NCT01045772	Charite University, Berlin, Germany	user2@example.com	None	2009-01-31	2010-09-30	2011-09-30	-	-	2025-07-14
Baclofen for the Treatment of Alcohol Dependence	NCT01266655	Charite University, Berlin, Germany	user2@example.com	None	2011-02-28	2014-05-31	2015-05-31	-	-	2025-07-14
Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer	NCT02753036	Charite University, Berlin, Germany	user2@example.com	None	2016-01-01	2023-06-30	2024-06-30	-	-	2025-07-14
Acceptance of Complementary Medicine in Germany	NCT05530720	Charite University, Berlin, Germany	user2@example.com	None	2022-09-19	2022-10-17	2023-10-17	-	-	2025-07-14
Cupping in Osteoarthritis of the Knee	NCT01057043	Charite University, Berlin, Germany	user2@example.com	None	2010-01-31	2011-01-31	2012-01-31	-	-	2025-07-14
Prevalence of Wound Healing Disturbances in Geriatric Inpatients (WONDER Study)	NCT03314350	Charite University, Berlin, Germany	user2@example.com	None	2017-11-01	2021-01-31	2022-01-31	-	-	2025-07-14
DIGIPREDICT-Physio-DE	NCT05886569	Charite University, Berlin, Germany	user2@example.com	None	2023-05-25	2023-11-24	2024-11-24	-	-	2025-07-14
Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients	NCT01992237	Charite University, Berlin, Germany	user2@example.com	None	2013-10-31	2018-06-30	2019-06-30	-	-	2025-07-14
Zevalin® First Line in Follicular Lymphoma	NCT00772655	Charite University, Berlin, Germany	user2@example.com	None	2007-10-31	2015-06-30	2016-06-30	-	-	2025-07-14
OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia	NCT06136390	Charite University, Berlin, Germany	user2@example.com	None	2023-09-30	2024-12-30	2025-12-30	-	-	2025-07-14
Patient Survey as a Tool to Quality Assurance and Quality Improvement	NCT02413775	Charite University, Berlin, Germany	user2@example.com	None	2015-04-30	2021-09-30	2022-09-30	-	-	2025-07-14
D2E7-Early AS	NCT00235105	Charite University, Berlin, Germany	user2@example.com	None	2005-03-31	2007-06-30	2008-06-30	-	-	2025-07-14
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders	NCT03671005	Charite University, Berlin, Germany	user2@example.com	None	2018-05-01	2021-02-28	2022-02-28	-	-	2025-07-14
Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis	NCT05231239	Charite University, Berlin, Germany	user2@example.com	None	2021-01-01	2023-01-31	2024-01-31	-	-	2025-07-14
Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients	NCT05192655	Charite University, Berlin, Germany	user2@example.com	None	2021-12-01	2026-12-01	2027-12-01	-	-	2025-07-14
Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach	NCT05334888	Charite University, Berlin, Germany	user2@example.com	None	2022-08-29	2027-12-31	2028-12-31	-	-	2025-07-14
Bilastine Updosing in Chronic Spontaneous Urticaria	NCT02213367	Charite University, Berlin, Germany	user2@example.com	None	2014-07-31	2016-03-31	2017-03-31	-	-	2025-07-14
Intensive Care Unit Risk Score	NCT04661735	Charite University, Berlin, Germany	user2@example.com	None	2006-01-01	2025-12-31	2026-12-31	-	-	2025-07-14
Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection	NCT05211011	Charite University, Berlin, Germany	user2@example.com	None	2018-01-23	2023-04-30	2024-04-30	-	-	2025-07-14
Cold Urticaria Treatment With Xolair	NCT01580592	Charite University, Berlin, Germany	user2@example.com	None	2012-04-30	2015-02-28	2016-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance